-
#MediQuotes | Healthcare in India is reactive. Patients and clinicians resort to medical investigations only when they have to, not because they want to. - Dr Sanjay Arora, Founder and MD, Suburban Diagnostics#pharma#pharmanews#health#healthcarepic.twitter.com/Qq2L37sYhR
-
#Breaking@Rebiotix, a Ferring company, has completed enrollment for the Phase 3 trial of its microbiota-based investigational therapy for recurrent#cdiff infection – the first trial of its kind using the#microbiome. Read more here:https://bit.ly/2Sckwi4#pharmanews#guthealthpic.twitter.com/iOCCs4tawh
-
Regeneron has extended its collaboration with the Health and Human Services (HHS) to develop innovative treatments to tackle the new
#coronavirus.#PharmaNews#Pharmapic.twitter.com/xUVuz0iuSo
-
GSK to sell its state-of-the-art tablet facility at Vemagal, Karnataka https://health.economictimes.indiatimes.com/news/pharma/gsk-announces-sale-of-vemagal-plant-takes-rs-640-crore-hit-on-account-of-zinetac-recall/73949270 …
#BreakingNewsPharma#pharmanews#breakingnews#gsk#tablets#pharmaceuticals#pharmaceutical#pharmacy#pharmacist#pharmaindustry#pharmaceuticalindustrypic.twitter.com/jBtRJQze7z
-
#MediQuotes | To end the#HIV pandemic, we must continue to outthink this virus - Mary Rodgers, ‘virus hunter’, Principal Scientist and Head, Abbott Global Surveillance Center#pharma#pharmanews#health#healthcarepic.twitter.com/Lx26iG9ehJ
-
China announces 304 deaths, 14,380 total cases of coronavirus outbreak https://economictimes.indiatimes.com/news/international/world-news/china-announces-304-deaths-14380-total-cases-of-coronavirus-outbreak/articleshow/73862095.cms …
#pharmanews#breakingnews#coronavirus#chinavirus#china#pharmanews#pharmaceuticals#pharmaindustry#pharmacy#pharmacist#CoronavirusOutbreak#pharmapic.twitter.com/1BOwcjg3Lj
-
All you need to know when
@WHO@DrTedros has declared public health emergency of international concern over the outbreak of Novel Coronavirus#nCoV2019@MoHFW_INDIA#2019nCoV#Coronavirus#NovelCoronavirus#pharmedge#healthcare#healthnews#healthcarenews#pharmanews pic.twitter.com/0ZoxymahU6
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.